EP 3595776 A1 20200122 - FLUTICASONE EXTENDED-RELEASE FORMULATIONS AND METHODS OF USE THEREOF
Title (en)
FLUTICASONE EXTENDED-RELEASE FORMULATIONS AND METHODS OF USE THEREOF
Title (de)
RETARD-FORMULIERUNGEN VON FLUTICASON UND VERFAHREN ZUR VERWENDUNG DAVON
Title (fr)
FORMULATIONS À LIBÉRATION PROLONGÉE DE FLUTICASONE ET LEURS PROCÉDÉS D'UTILISATION
Publication
Application
Priority
- US 201762473029 P 20170317
- US 2018022848 W 20180316
Abstract (en)
[origin: WO2018170386A1] This disclosure relates to extended-release fluticasone propionate (FP) formulations that include small microparticles and/or nanoparticles and methods of using these extended-release FP formulations for treating pain and/or inflammation in a subject.
IPC 8 full level
A61P 17/02 (2006.01); A61P 29/00 (2006.01)
CPC (source: EP US)
A61K 9/0019 (2013.01 - EP US); A61K 9/1647 (2013.01 - EP US); A61K 9/5153 (2013.01 - EP); A61K 31/56 (2013.01 - US); A61K 31/58 (2013.01 - EP); A61P 17/02 (2017.12 - EP); A61P 19/02 (2017.12 - EP)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2018170386 A1 20180920; EP 3595776 A1 20200122; EP 3595776 A4 20200930; US 2020009156 A1 20200109
DOCDB simple family (application)
US 2018022848 W 20180316; EP 18768195 A 20180316; US 201816493437 A 20180316